COPD Foundation

Trusted

http://www.copdfoundation.org/

Last activity: 08.10.2026

Active

Categories: EdTechHealthTechLearnResearchServiceVideo

Join our #LaceUpforLungs challenge to help us go the distance for COPD awareness.

View our video: https://youtu.be/bSMe9qwqMt4

Learn more: https://copdf.co/3AMqR9a

Twitter Facebook Instagram LinkedIn Youtube Email

Likes

25.97K

Website visits

183.1K /mo.

Mentions

Overview

Location

United States, District of Columbia, Washington

Employees

51-200

Founded date

2004

Mentions in press and media 14

Date	Title	Description
Sign up to see	Sign up to see	Sign up to see
Jul 7, 2026	Widespread Hospital Discharge Delays Due to Lack of Adequate Home Oxygen Access	A national survey found that limited access to high-flow home oxygen is delaying hospital discharges and increasing risks and costs for patients and the healthcare system. WASHINGTON, July 7, 2026 /PRNewswire-PRWeb/ -- Across the country, p...
Aug 5, 2025	British HealthTech startup Wanda Health raises €2.1 million to scale intelligent virtual care and reduce hospital readmissions	Bristol-based Wanda Health, an intelligent platform for Remote Patient Monitoring (RPM) and Virtual Care, has successfully closed an investment round of €2.1 million in order to reduce hospitalisations and readmissions by collecting real-ti...
Feb 23, 2022	ENA Respiratory and the COPD Foundation Partner to Develop Pan-Antiviral Nasal Spray	-- INNA-051 is being developed to stimulate innate immunity and reduce the incidence and severity of respiratory viral infections, such as COVID-19, rhinovirus, or influenza in populations at-risk of complications that include individuals w...
Feb 23, 2022	ENA Respiratory and the COPD Foundation Partner to Develop Pan-Antiviral Nasal Spray	ENA Respiratory, a clinical-stage pharmaceutical company developing INNA-051, a first-in-class broad-spectrum antiviral innate immunomodulator for pre- and post-exposure prophylaxis of respiratory viral infections, including COVID-19 in pop...
Jun 15, 2021	ENA Respiratory Advances COVID-19 Preventative Therapy through AU$32 Million Funding Round	Round jointly led by Brandon Capital and Minderoo Foundation with co-investment from Uniseed will support the clinical development of INNA-051 Company appoints President and Chief Scientific Officer of the COPD Foundation and respiratory th...
Jun 15, 2021	ENA Respiratory Advances COVID-19 Preventative Therapy through AU$32 Million Fund Raise	ENA Respiratory, a biotechnology company developing a first-in-class nasal spray for the prevention of COVID-19 and other respiratory viral infections, announced today that it secured up to AU$32m investment and appointed Ruth Tal-Singer, P...
Apr 29, 2016	COPD Foundation and Evidera Awarded Best Personalized Medicine Advance or Application at the CARE Awards	Evidera and the COPD Foundation were awarded Best Personalized Medicine Advance or Application at Informa’s 2016 Clinical & Research Excellence (CARE) Awards, held on April 27 in Boston, MA. Evidera, a global leader in health economics...
Nov 18, 2015	How Technology, Activity and Song Are Helping People With COPD Live Better	After the curtain rose, a young woman sang the first line of Sting’s “Every Breath You Take” in a slow but powerful voice. Two more soloists followed, and then an entire chorus of 18 people filled the historic auditorium with a rich, comman...
Jan 23, 2014	Using Open Innovation to Deliver High-End Healthcare Disruption	For example, in 1995, the BMWZ3 Roadster paired with James Bond in the movie Golden Eye, and the resulting product created buzz in the Neiman Marcus Holiday Catalog that year. In 2011, Target tapped Missoni to develop a 400-product line ref...
Nov 4, 2013	COPD advances: New focus on biomarkers, genetic analysis and continuous oxygen	Spirometry continues to be an important tool for generating pneumotachographs, which are helpful in assessing COPD. Along with promoting smoking cessation, vaccinations, Alpha-1 testing and exercise, patient health status should be monitore...
	COPD advances: New focus on biomarkers, genetic analysis and continuous oxygen	Many treatment options exist for patients with chronic obstructive pulmonary disease (COPD). Most of them have historically focused on improving airway obstruction, so the patient can exhale more easily and with less wheezing. While this is...
	Using Open Innovation to Deliver High-End Healthcare Disruption	The lifeblood of any successful company stems from a sustained stream of commercially viable innovations, both incremental and breakthrough. As any seasoned executive will tell you, maintaining that steady stream is one of the most difficul...
	ALung Announces that the Independent Data and Safety Monitoring Board (DSMB) Recommends Continuation of VENT-AVOID Trial and Reports that Significant Progress Continues with their Clinical Trial Programs	PITTSBURGH–(BUSINESS WIRE)–ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced today the achievement of a maj...

Reviews 0

FAQ about COPD Foundation

When was COPD Foundation founded?

COPD Foundation was founded in 2004.

What has the press written about COPD Foundation?

Parsers VC has collected 14 articles mentioning COPD Foundation, among them “Widespread Hospital Discharge Delays Due to Lack of Adequate Home Oxygen Access” (Jul 7, 2026) and “British HealthTech startup Wanda Health raises €2.1 million to scale intelligent virtual care and reduce hospital readmissions” (Aug 5, 2025).

Is COPD Foundation still active?

Yes, COPD Foundation is active; its latest activity on Parsers VC dates from Oct 8, 2026.